We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+20.93%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$237B
AUM Growth
+$24.6B
Cap. Flow
-$17.5B
Cap. Flow %
-7.37%
Top 10 Hldgs %
15.61%
Holding
8,813
New
706
Increased
2,953
Reduced
4,001
Closed
776

Sector Composition

Rank Sector Weight
1 Technology 10.78%
2 Healthcare 6.25%
3 Consumer Discretionary 6.24%
4 Financials 5.99%
5 Communication Services 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHIO icon
6426
Phio Pharmaceuticals
PHIO
$12.1M
$24K ﹤0.01%
103
+98
+1,960% +$23.5K
PULS icon
6427
PGIM Ultra Short Bond ETF
PULS
$18.3B
$24K ﹤0.01%
497
-1,382
-74% -$68.3K
LNAI
6428
Lunai Bioworks
LNAI
$10.9M
$24K ﹤0.01%
71
-42
-37% -$12.7K
THNQ icon
6429
ROBO Global Artificial Intelligence ETF
THNQ
$453M
$24K ﹤0.01%
+818
New +$22.3K
TWI icon
6430
Titan International
TWI
$475M
$24K ﹤0.01%
16,579
-15,927
-49% -$21.4K
URE icon
6431
ProShares Ultra Real Estate
URE
$59.7M
$24K ﹤0.01%
449
-607
-57% -$30.4K
VUSE icon
6432
Vident US Equity Strategy ETF
VUSE
$691M
$24K ﹤0.01%
+870
New +$22.5K
ZIG icon
6433
The Acquirers Fund
ZIG
$32.7M
$24K ﹤0.01%
1,147
+24
+2% +$498
RNTX
6434
Rein Therapeutics
RNTX
$69.9M
$24K ﹤0.01%
+1,032
New +$16.8K
TCON
6435
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$24K ﹤0.01%
632
+569
+903% +$22.5K
TBLT
6436
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$24K ﹤0.01%
3
+2
+200% +$23K
NVCN
6437
DELISTED
Neovasc Inc.
NVCN
$24K ﹤0.01%
406
+401
+8,020% +$25K
EPZM
6438
DELISTED
Epizyme, Inc
EPZM
$24K ﹤0.01%
1,500
-2,898
-66% -$50.6K
ZAGG
6439
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$24K ﹤0.01%
7,788
-11,099
-59% -$34.9K
BCTF
6440
DELISTED
Bancorp 34, Inc. Common Stock
BCTF
$24K ﹤0.01%
2,158
+639
+42% +$6.76K
CYRXW
6441
DELISTED
CryoPort, Inc. Warrants
CYRXW
$24K ﹤0.01%
900
-175
-16% -$3.37K
SDI
6442
DELISTED
Standard Diversified Inc. Class A Common Stock
SDI
$24K ﹤0.01%
1,858
+762
+70% +$9.34K
ASHX
6443
DELISTED
Xtrackers MSCI China A Inclusion Equity ETF
ASHX
$24K ﹤0.01%
1,097
-899
-45% -$18.2K
CHIX
6444
DELISTED
Global X MSCI China Financials ETF
CHIX
$24K ﹤0.01%
1,777
-1,065
-37% -$14.6K
HEWW
6445
DELISTED
iShares Currency Hedged MSCI Mexico ETF
HEWW
$24K ﹤0.01%
1,751
+95
+6% +$1.29K
ALAR
6446
Alarum Technologies
ALAR
$14.3M
$23K ﹤0.01%
+1,388
New +$19.5K
CARM
6447
DELISTED
Carisma Therapeutics
CARM
$23K ﹤0.01%
1,595
+233
+17% +$3.14K
CRDF icon
6448
Cardiff Oncology
CRDF
$77.2M
$23K ﹤0.01%
4,522
-5,088
-53% -$10.4K
ENTA icon
6449
Enanta Pharmaceuticals
ENTA
$400M
$23K ﹤0.01%
456
-4,447
-91% -$230K
FAAR icon
6450
First Trust Alternative Absolute Return Strategy ETF
FAAR
$189M
$23K ﹤0.01%
+881
New +$22.6K

Similar funds

UBS Group's Q2 2020 Portfolio in Review

As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.

  • UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
  • UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
  • UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
  • UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
  • UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
  • UBS Group opened 706 new positions and closed 776 in Q2 2020.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.